• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Vero Biotech raises $30M for tankless nitric oxide delivery system

January 11, 2023 By Sean Whooley

Vero Biotech Genosyl iNO delivery system
[Image courtesy of Vero Biotech]
Vero Biotech announced today that it raised $30 million to support its Genosyl inhaled nitric oxide (iNO) delivery system.

The financing comes just days after the company received FDA approval for Genosyl. The third-generation Genosyl delivery system features faster dosing, simpler workflow and operational efficiency.

Petrichor, a healthcare-dedicated growth capital provider, led the financing.

Atlanta-based Vero Biotech said in a news release that it plans to use proceeds to support commercialization for Genosyl.

The system speeds up dosing with an adaptive sensor and automated cassette activation feature. These offerings cut the time needed to achieve the desired dose. The company designed Genosyl so clinicians can work from one console. Each console includes a dual cassette bay that transitions cassettes automatically.

Vero also improved Genosyl’s user interface and reduced the size and weight of its disposable cassettes. These improvements to operational efficiency alleviate storage constraints within hospitals.

“This funding represents our commitment to the continuous development of the Genosyl delivery system, as well as to neonatal intensive care and the acute care hospital community in providing solutions to the challenges they face,” said Brent V. Furse, CEO and president, Vero Biotech. “We are grateful for the partnership with Petrichor, the confidence they have placed in Vero Biotech, and their recognition of our commercial success to date and strategies for further expansion.”

New member joins Vero Biotech board on the back of financing

As part of the financing, Petirchor partner Patrick Lally joined Vero Biotech’s board of directors. The company declined to disclose further details of its financing.

Patrick Lally, Partner of Petrichor, has joined the VERO Biotech Board of Directors. Details of the financing were not disclosed.

“Vero Biotech has rapidly established itself as a leader in neonatal intensive care through the commercial success of Genosyl delivery system, with its tankless system representing the first innovation in the delivery of inhaled nitric oxide approved by the FDA in 20 years,” said Lally. “We have been impressed with Vero Biotech’s commercial growth in addition to its commitment to continued innovation, evidenced by the recent FDA approval for its third-generation product design.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pediatrics, Pharmaceuticals, Respiratory Tagged With: Vero Biotech

IN CASE YOU MISSED IT

  • Medtronic to invest $50M in India Diabetes center
  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS